Drugs / CHG0521
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06609070 | Oct 2024 → Aug 2026 overdue | oral cavity squamous cell carcinoma | Guangzhou University of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHG0521 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06609070 ↗ |
| Route | Oral | “The subjects will receive an oral coating of CHG0521 in the form of drops” NCT06609070 ↗ |